发明名称 Peptides that ellicit T cellular immunity
摘要 The invention relates to peptides from cancer related protein products of frameshift mutated genes, said protein products eliciting T cellular immunity, for use in cancer vaccines and compositions for anticancer treatment. In particular the invention relates to protein products of frameshift mutated BAX or TGF²RII genes.
申请公布号 EP2374814(B1) 申请公布日期 2014.03.19
申请号 EP20100183767 申请日期 1999.05.03
申请人 GEMVAX AS 发明人 GAUDERNACK, GUSTAV;ERIKSEN, JON AMUND;MOELLER, MONA;GJERTSEN, MARIANNE KLEMP;SAETERDAL, INGVIL
分类号 C07K14/47;C12N15/09;A61K31/7088;A61K35/76;A61K38/00;A61K38/16;A61K39/00;A61K48/00;A61P35/00;C07K14/82;C12N15/12;G01N33/574 主分类号 C07K14/47
代理机构 代理人
主权项
地址